Skip to main content
Hindustan Agrigenetics Ltd. logo

Hindustan Agrigenetics Ltd. — Investor Relations & Filings

Ticker · 519574 ISIN · INE092301014 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 286 across all filing types
Latest filing 2025-08-14 Regulatory Filings
Country IN India
Listing BSE.NS 519574

About Hindustan Agrigenetics Ltd.

http://hindustanagrigenetics.co.in/

Hindustan Agrigenetics Ltd. focuses on the research, development, and commercialization of high-yielding hybrid seeds. The company utilizes advanced plant breeding techniques and biotechnology to enhance crop productivity and resilience. Its product portfolio encompasses a diverse range of field crops, including maize, sunflower, pearl millet, and paddy, alongside various vegetable seed varieties. The organization maintains dedicated research and development facilities to innovate seed genetics, targeting improved resistance to pests, diseases, and environmental stressors. By providing high-performance seeds, the company supports agricultural efficiency and addresses the evolving needs of the farming community.

Recent filings

Filing Released Lang Actions
Approval of un-audited financial results for the quarter ended 30.06.2025.
Regulatory Filings
2025-08-14 English
Un-audited financial results for the quarter ended 30.06.2025.
Regulatory Filings
2025-08-14 English
Hindustan Agrigenetics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve The Un-audited Financial ....
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about a scheduled Board Meeting to consider and approve the unaudited financial results for the quarter ended June 30, 2025. It references compliance with SEBI regulations and insider trading rules. The document does not contain any financial data or results itself, but rather is an announcement of an upcoming board meeting where financial results will be reviewed. The document length is short (1627 characters) and it serves as a notification rather than a report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related management information.
2025-08-08 English
Filing a copy of certificate under Reg.74 (5) of SEBI (DP) Regulation for the period ending 30.06.2025
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange secretary, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025. It includes certificates from registrars confirming details of securities dematerialized/rematerialized have been furnished to stock exchanges. The document is short (3537 characters) and serves as a compliance confirmation rather than a financial report or detailed filing. It does not contain financial statements or management discussion but is a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2025-07-09 English
INTIMATION OF CLOSURE OF TRADING WINDOW.
Regulatory Filings Classification · 95% confidence The document is a formal notice from Hindustan Agrigenetics Limited addressed to the stock exchange (BSE Limited) regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period during which insiders are prohibited from trading shares, linked to the upcoming declaration of the company's unaudited financial results for the first quarter ending 30.06.2025. The document does not contain any financial data or results itself, nor does it announce the results. It is an announcement related to trading restrictions ahead of financial results disclosure. Such notices are regulatory compliance announcements and do not fit into categories like Interim Report or Earnings Release. Given the nature and length of the document (1751 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-26 English
ISSUANCE OF DUPLICATE SHARE CERTIFICATE FOR THE LOST OF SHARE CERTIFICATE.
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the stock exchange (BSE Limited) under Regulation 39(3) of the SEBI Listing Regulations. It informs about the issuance of duplicate share certificates in lieu of original certificates reported lost. The content is a regulatory compliance announcement related to share certificate replacement, not a financial report, earnings release, or management discussion. The document length is 3271 characters, which is relatively short and primarily serves as a formal notification to the exchange. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like share issue or director dealings.
2025-06-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.